share_log

Nxu Inc | S-1: General form for registration of securities under the Securities Act of 1933

Nxu Inc | S-1: General form for registration of securities under the Securities Act of 1933

Nxu Inc | S-1：證券上市註冊聲明
美股SEC公告 ·  2024/12/31 05:15

Moomoo AI 已提取核心訊息

Nxu Inc. has filed to register up to 114,503,816 shares of Class A common stock for resale by selling stockholders. The shares include 6.8 million purchased shares and 107.7 million shares issuable upon exercise of warrants issued in a $3 million private placement on December 26, 2024.The company issued pre-funded warrants for 5.2 million shares, Series A warrants for up to 57.25 million shares, and Series B warrants for up to 45.25 million shares. The pre-funded warrants have a $0.0001 exercise price, Series A warrants $0.50, and Series B warrants $0.0001. Nxu will not receive proceeds from the resale but may receive proceeds if warrants are exercised.The filing also discloses Nxu's pending merger with Verde Bioresins, where Verde shareholders would own 95% of the combined company. Nxu had $2.2 million cash as of September 30, 2024 and warns of substantial doubt about its ability to continue as a going concern without additional funding.
Nxu Inc. has filed to register up to 114,503,816 shares of Class A common stock for resale by selling stockholders. The shares include 6.8 million purchased shares and 107.7 million shares issuable upon exercise of warrants issued in a $3 million private placement on December 26, 2024.The company issued pre-funded warrants for 5.2 million shares, Series A warrants for up to 57.25 million shares, and Series B warrants for up to 45.25 million shares. The pre-funded warrants have a $0.0001 exercise price, Series A warrants $0.50, and Series B warrants $0.0001. Nxu will not receive proceeds from the resale but may receive proceeds if warrants are exercised.The filing also discloses Nxu's pending merger with Verde Bioresins, where Verde shareholders would own 95% of the combined company. Nxu had $2.2 million cash as of September 30, 2024 and warns of substantial doubt about its ability to continue as a going concern without additional funding.
Nxu Inc.已提交註冊申請，計劃向賣方股東再出售最多114,503,816股A類普通股。這些股份包括680萬已購買的股份以及10770萬在2024年12月26日的300萬美元定向增發中發行的Warrants可發行的股份。該公司發行了520萬股的預付Warrants，最多爲5725萬股的A系列Warrants，以及最多爲4525萬股的B系列Warrants。預付Warrants的行使價格爲0.0001美元，A系列Warrants爲0.50美元，B系列Warrants爲0.0001美元。Nxu不會從轉售中獲得收益，但如果Warrants被行使，可能會獲得收益。該申請還披露了Nxu與Verde Bioresins的合併進展，Verde的股東將擁有合併公司95%的股份。截至2024年9月30日，Nxu的現金爲220萬美元，並警告在沒有額外資金的情況下持續經營的能力存在重大不確定性。
Nxu Inc.已提交註冊申請，計劃向賣方股東再出售最多114,503,816股A類普通股。這些股份包括680萬已購買的股份以及10770萬在2024年12月26日的300萬美元定向增發中發行的Warrants可發行的股份。該公司發行了520萬股的預付Warrants，最多爲5725萬股的A系列Warrants，以及最多爲4525萬股的B系列Warrants。預付Warrants的行使價格爲0.0001美元，A系列Warrants爲0.50美元，B系列Warrants爲0.0001美元。Nxu不會從轉售中獲得收益，但如果Warrants被行使，可能會獲得收益。該申請還披露了Nxu與Verde Bioresins的合併進展，Verde的股東將擁有合併公司95%的股份。截至2024年9月30日，Nxu的現金爲220萬美元，並警告在沒有額外資金的情況下持續經營的能力存在重大不確定性。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間